Blank check Health Sciences Acquisitions files for a $100 million IPO

Shutterstock photo

Health Sciences Acquisitions, a blank check company targeting the biopharma and medical technology sectors, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering.

The New York, NY-based company plans to raise $100 million by offering 10 million units at a price of $10. At $10, Health Sciences Acquisitions would command a market value of $125 million. The units consist of one share of common stock and one warrant to purchase half a share of common stock at $11.50 per whole share. 

Health Sciences Acquisitions was founded in 2018 and plans to list on the Nasdaq under the symbol HSACU. Chardan Capital Markets and UBS Investment Bank are the joint bookrunners on the deal.

The article Blank check Health Sciences Acquisitions files for a $100 million IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO) , Renaissance International ETF (symbol: IPOS) , or separately managed institutional accounts may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines , IPOs

More from Renaissance Capital


Renaissance Capital

Renaissance Capital


Research Brokers before you trade

Want to trade FX?